WASHINGTON — Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.
Merck seeks OK for anti-COVID pill
Drugmaker submits request to FDA